Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
6.
Infect Control Hosp Epidemiol ; 41(3): 337-341, 2020 03.
Article in English | MEDLINE | ID: mdl-31915082

ABSTRACT

Hospital-acquired infections remain a common cause of morbidity and mortality despite advances in infection prevention through use of bundles, environmental cleaning, antimicrobial stewardship, and other best practices. Current prevention strategies and further hospital-acquired infection reduction are limited by lack of recognition of the role that host-microbe interactions play in susceptibility and by the inability to analyze multiple risk factors in real time to accurately predict the likelihood of a hospital-acquired infection before it occurs and to inform medical decision making. Herein, we examine the value of incorporating the damage-response framework and host attributes that determine susceptibility to infectious diseases known by the acronym MISTEACHING (ie, microbiome, immunity, sex, temperature, environment, age, chance, history, inoculum, nutrition, genetics) into infection prevention strategies using machine learning to drive decision support and patient-specific interventions.


Subject(s)
Cross Infection/epidemiology , Cross Infection/prevention & control , Infection Control/methods , Machine Learning , Risk Assessment/methods , Decision Support Systems, Clinical , Female , Humans , Male , Microbiota , Models, Biological
7.
Am J Infect Control ; 48(1): 108-111, 2020 01.
Article in English | MEDLINE | ID: mdl-31358422

ABSTRACT

In a 12-month study, a nurse driven protocol was implemented at a tertiary academic medical center. The purpose of the nurse driven protocol was to identify community-onset Clostridioides difficile infections, expeditiously isolate patients with presumed C difficile diarrheal illness, and prevent transmission while simultaneously decreasing the incidence of hospital-onset C difficile. The overall adherence to fidelity of the protocol was poor and failed to have a significant impact on infection rates.


Subject(s)
Clostridium Infections/nursing , Cross Infection/prevention & control , Diarrhea/nursing , Enterocolitis, Pseudomembranous/nursing , Infection Control/organization & administration , Academic Medical Centers , Clostridioides difficile , Clostridium Infections/microbiology , Diarrhea/microbiology , Enterocolitis, Pseudomembranous/microbiology , Humans , Incidence , Nursing Service, Hospital , Patient Isolation
8.
Am J Infect Control ; 47(12): 1471-1473, 2019 12.
Article in English | MEDLINE | ID: mdl-31400883

ABSTRACT

BACKGROUND: Multiple studies have shown that bathing with chlorhexidine gluconate (CHG) wipes reduces hospital-acquired infections (HAIs). We employed a mathematical model to assess the impact of CHG patient bathing on central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), and hospital-onset Clostridium difficile (C diff) infections and the associated costs. METHODS: Using a Markov chain, we examined the effect of CHG bathing compliance on HAI outcomes and the associated costs. Using estimates from 2 different studies on CHG bathing effectiveness for CLABSI, CAUTI, and C diff, the number of HAIs per year were estimated along with associated costs. The simulations were conducted, assuming CHG bathing at varying compliance rates. RESULTS: At 32% reduction in HAI incidence, increasing CHG bathing compliance from 60% to 90% results in 20 averted infections and $815,301.75 saved cost. CONCLUSIONS: As CHG bathing compliance increases, yearly HAIs decrease, and the overall cost associated with the HAIs also decreases.


Subject(s)
Anti-Infective Agents, Local/economics , Baths/methods , Catheter-Related Infections/prevention & control , Chlorhexidine/analogs & derivatives , Clostridium Infections/prevention & control , Cross Infection/prevention & control , Models, Statistical , Catheter-Related Infections/economics , Chlorhexidine/economics , Clostridium Infections/economics , Computer Simulation , Costs and Cost Analysis/statistics & numerical data , Cross Infection/economics , Humans , Intensive Care Units , Patient Compliance/statistics & numerical data
9.
Am J Infect Control ; 47(10): 1277-1279, 2019 10.
Article in English | MEDLINE | ID: mdl-31128982

ABSTRACT

We implemented an electronic medical record (EMR) decision support tool for ordering urine cultures per evidence-based guidelines. Following the EMR change, we found a significant increase in proportion of cultures ordered for catheterized intensive care unit (ICU) patients meeting guidelines. We surveyed providers and found poor understanding of urine culture guidelines for catheterized ICU patients. EMR-based interventions and educational opportunities have potential to improve urine culture guideline adherence and reduce unnecessary testing and antibiotic use.


Subject(s)
Critical Care/standards , Guideline Adherence/standards , Urine/chemistry , Anti-Bacterial Agents/therapeutic use , Electronic Health Records/standards , Humans
10.
Infect Control Hosp Epidemiol ; 40(4): 473-475, 2019 04.
Article in English | MEDLINE | ID: mdl-30777579

ABSTRACT

We investigated the impact of discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus infected or colonized patients on central-line associated bloodstream infection rates at an academic children's hospital. Discontinuation of contact precautions with a bundled horizontal infection prevention platform resulted in no adverse impact on CLABSI rates.


Subject(s)
Bacteremia/epidemiology , Catheter-Related Infections/epidemiology , Catheter-Related Infections/microbiology , Cross Infection/prevention & control , Gram-Positive Bacterial Infections/epidemiology , Infection Control/methods , Academic Medical Centers , Adolescent , Child , Child, Preschool , Female , Hospitals, Pediatric , Humans , Infant , Male , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/epidemiology , Vancomycin Resistance , Virginia/epidemiology
11.
Am J Infect Control ; 47(8): 1030-1031, 2019 08.
Article in English | MEDLINE | ID: mdl-30638675

ABSTRACT

We investigated the compliance of health care personnel with a voluntary, institution-wide bare below the elbows (BBE) approach to inpatient care at an academic medical center. BBE compliance increased significantly across all provider types over a 2-year period. The overall compliance with BBE by health care personnel nearly doubled from 2016-2017, increasing significantly from 40% to 84%.


Subject(s)
Academic Medical Centers , Clothing , Health Personnel , Infection Control/methods , Bacterial Infections/prevention & control , Cross Infection/prevention & control , Guideline Adherence , Hand Disinfection , Humans
12.
Curr Infect Dis Rep ; 20(10): 39, 2018 Aug 01.
Article in English | MEDLINE | ID: mdl-30069834

ABSTRACT

PURPOSE OF REVIEW: We aim to systematically review the literature on the effectiveness of pediatric antimicrobial stewardship programs (ASPs) and antimicrobial stewardship (AS) strategies in the United States (US) inpatient setting. Furthermore, we review current gaps and challenges for unique pediatric populations and those in ambulatory settings. RECENT FINDINGS: Misuse and overuse of antimicrobials have been identified as key factors for antimicrobial resistance (AR). Multiple professional organizations support the implementation of hospital-based ASPs to decrease antimicrobial consumption, improve patient outcomes, and reduce healthcare costs. There is limited data on the effectiveness of inpatient pediatric ASPs and AS strategies in unique populations. Furthermore, there is a paucity of evidence on ASPs in ambulatory settings. This review contributes to the growing body of evidence that supports the use of pediatric ASPs to optimize antimicrobial therapy in the inpatient setting as well as in unique patient populations and ambulatory settings. Active stewardship is critical and antimicrobial consumption is a key outcome metric for programs.

13.
J Immunol ; 181(10): 6738-46, 2008 Nov 15.
Article in English | MEDLINE | ID: mdl-18981091

ABSTRACT

The programmed death (PD)-1 molecule and its ligands (PD-L1 and PD-L2), negative regulatory members of the B7 family, play an important role in peripheral tolerance. Previous studies have demonstrated that PD-1 is up-regulated on T cells following TCR-mediated activation; however, little is known regarding PD-1 and Ag-independent, cytokine-induced T cell activation. The common gamma-chain (gamma c) cytokines IL-2, IL-7, IL-15, and IL-21, which play an important role in peripheral T cell expansion and survival, were found to up-regulate PD-1 and, with the exception of IL-21, PD-L1 on purified T cells in vitro. This effect was most prominent on memory T cells. Furthermore, these cytokines induced, indirectly, the expression of PD-L1 and PD-L2 on monocytes/macrophages in PBMC. The in vivo correlate of these observations was confirmed on PBMC isolated from HIV-infected individuals receiving IL-2 immunotherapy. Exposure of gamma c cytokine pretreated T cells to PD-1 ligand-IgG had no effect on STAT5 activation, T cell proliferation, or survival driven by gamma c cytokines. However, PD-1 ligand-IgG dramatically inhibited anti-CD3/CD28-driven proliferation and Lck activation. Furthermore, following restimulation with anti-CD3/CD28, cytokine secretion by both gamma c cytokine and anti-CD3/CD28 pretreated T cells was suppressed. These data suggest that gamma c cytokine-induced PD-1 does not interfere with cytokine-driven peripheral T cell expansion/survival, but may act to suppress certain effector functions of cytokine-stimulated cells upon TCR engagement, thereby minimizing immune-mediated damage to the host.


Subject(s)
Antigens, CD/biosynthesis , Apoptosis Regulatory Proteins/biosynthesis , Interleukin-15/immunology , Interleukin-2/immunology , Interleukin-7/immunology , Interleukins/immunology , Lymphocyte Activation/immunology , Antigens, CD/immunology , Apoptosis Regulatory Proteins/immunology , B7-H1 Antigen , Cells, Cultured , Cytokines , HIV Infections/drug therapy , HIV Infections/immunology , Humans , Intercellular Signaling Peptides and Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins/immunology , Interleukin-2/therapeutic use , Programmed Cell Death 1 Ligand 2 Protein , Programmed Cell Death 1 Receptor , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...